Cargando…

PS129. Low TNFAIP3 was normalized with antidepressant in patients with major depressive disorder

Detalles Bibliográficos
Autor principal:	Hung, Yi-Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616725/ http://dx.doi.org/10.1093/ijnp/pyw043.129

Ejemplares similares

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder
por: Hung, Yi-Yung, et al.
Publicado: (2015)

PS76. Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
por: Lee, Chun-Te, et al.
Publicado: (2016)

PS188. Predict value of functional topological features for early response to antidepressant treatment in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

PS78. Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder
por: Cho, Se Hoon, et al.
Publicado: (2016)

PS102. Apathy in elderly depression and the antidepressant response
por: Shimano, Takahisa, et al.
Publicado: (2016)

PS82. Does Serum Amyloid ß-Protein predict the Response to Antidepressant treatment in Major Depression?
por: Inoue, Megumi, et al.
Publicado: (2016)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

PS180. Relationship between frontal lobe function and antidepressant treatment in bipolar disorder and major depressive disorder: a near-infrared spectroscopy study
por: Tomioka, Hiroi, et al.
Publicado: (2016)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

PS96. The change of prescribing patterns for inpatients of major depressive disorder
por: Kim, Hyeri, et al.
Publicado: (2016)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
por: Lee, K.H., et al.
Publicado: (2022)

PS195. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2016)

PS163. Serotonin Transporter Polymorphism in Severe Major Depressive Disorder in Indonesia
por: Arlisa, Wulandari, et al.
Publicado: (2016)

PS29. Genetic of Antidepressant Response in Obsessive-Compulsive Disorder and Body Dysmorphic Disorder
por: Zai, Gwyneth, et al.
Publicado: (2016)

The effect of antidepressant treatment on white matter integrity in Major Depression
por: Tourjman, S., et al.
Publicado: (2022)

PS50. The serum oxytocin levels among major depressive and bipolar II disorder
por: Lien, Yueh-Ju, et al.
Publicado: (2016)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
por: Bartova, Lucie, et al.
Publicado: (2016)

PS90. Differences in hypochondriasis between Korean and American outpatients with major depressive disorder
por: Kim, Jiyeon, et al.
Publicado: (2016)

SIGIRR and TNFAIP3 Are Differentially Expressed in Both PBMC and TNF-α Secreting Cells of Patients With Major Depressive Disorder
por: Lin, Chin-Chuen, et al.
Publicado: (2021)

Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
por: Ter Hark, S., et al.
Publicado: (2023)

PS93. Repeated Low-Grade Inflammation Increases the Risk of Antidepressant-Resistant Depression: A Nationwide Population-Based Cohort Study
por: Li, Cheng-Ta, et al.
Publicado: (2016)

PS32. Longitudinal survey of antidepressants use in bipolar disorder: prospective chart review
por: Kikuchi, Toshiaki, et al.
Publicado: (2016)

PS194. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder
por: Kim, Eun Young, et al.
Publicado: (2016)

PS221. Major depressive disorder and initial insulin hyposecretion in oral glucose tolerance test
por: Aizawa, E, et al.
Publicado: (2016)

PS68. A retrospective study for predictors of bipolar disorder with a major depressive episode
por: Muraoka, Hiroyuki, et al.
Publicado: (2016)

PS77. No different treatment outcome of Mirtazapine with Major Depression Patients with MAOA Gene Polymorphism
por: Chien, Chia Chang, et al.
Publicado: (2016)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Less basal thyrotropin levels predict antidepressant response in patients with major depression
por: Navinés, R., et al.
Publicado: (2022)

PS56. A smaller percentage of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment convert to bipolar disorder
por: Wada, Ken, et al.
Publicado: (2016)

PS203. The correlation between high-density lipoprotein and serum brain-derived neurotrophic factor levels in patients with major depressive disorder
por: Yang, Meng Fan, et al.
Publicado: (2016)

PS246. Psychological Dependence on Antidepressants in Patient with Panic Disorder: A Cross-Sectional Study
por: Fujii, Kazuhito, et al.
Publicado: (2016)

PS181. A study of hippocampal volumes in first-episode, drug-naïve major depression disorder.
por: Wang, Ying-Chih, et al.
Publicado: (2016)

PS238. Altered balance between monoamine metabolites in human cerebrospinal fluid with major depressive disorder.
por: Yoon, Hyung Shin, et al.
Publicado: (2016)

PS177. Gray matter abnormalities in individuals with major depressive disorder: a focus on the effects of childhood abuse
por: Ahn, Sung Jun, et al.
Publicado: (2016)

PS151. Adjunctive brexpiprazole (OPC-34712) in patients with major depressive disorder and anxiety symptoms: an exploratory study
por: Davis, Lori, et al.
Publicado: (2016)

PS162. Genetic role of CSNK1E on circadian and childhood characteristics of the patients with major depressive disorder
por: Joo, Eun-Jeong, et al.
Publicado: (2016)

PS166. Relationship of Hippocampal asymmetry and cognitive function in first-episode drug naïve major depressive disorder
por: Chen, Ching-Wen, et al.
Publicado: (2016)

PS173. A prospective study of structural connectivity in adolescents with major depressive disorder: A preliminary study
por: Lee, Moon-Soo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9bebh1i9cdvuvlern1kvcek0ds